Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruwen Jou

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
International Journal of Antimicrobial Agents|September 3, 2025
Evaluation of the Roche cobas MTB and MTB-RIF/INH for detecting Mycobacterium tuberculosis complex and resistance to isoniazid and rifampicin: A prospective, multicenter diagnostic accuracy studyShun-Chung Hsueh, Chieh-Lung Chen, Chang-Ru Lin, et al.
Emerging Infectious Diseases|May 20, 2015
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countriesEkaterina V Kurbatova, Tracy Dalton, Julia Ershova, et al.
Plos Medicine|December 30, 2015
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyCourtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, et al.
Journal of Clinical Microbiology|October 27, 2021
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective <i>In Vitro</i> Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB IsolatesKoné Kaniga, Rumina Hasan, Ruwen Jou, et al.
The Lancet. Infectious Diseases|May 14, 2017
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling studyAditya Sharma, Andrew Hill, Ekaterina Kurbatova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2014
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosisJ Peter Cegielski, Tracy Dalton, Martin Yagui, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 17, 2011
European 1: a globally important clonal complex of Mycobacterium bovisNoel H Smith, Stefan Berg, James Dale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
International Journal of Antimicrobial Agents|September 3, 2025
Evaluation of the Roche cobas MTB and MTB-RIF/INH for detecting Mycobacterium tuberculosis complex and resistance to isoniazid and rifampicin: A prospective, multicenter diagnostic accuracy studyShun-Chung Hsueh, Chieh-Lung Chen, Chang-Ru Lin, et al.
Emerging Infectious Diseases|May 20, 2015
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countriesEkaterina V Kurbatova, Tracy Dalton, Julia Ershova, et al.
Plos Medicine|December 30, 2015
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyCourtney M Yuen, Ekaterina V Kurbatova, Thelma Tupasi, et al.
Journal of Clinical Microbiology|October 27, 2021
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective <i>In Vitro</i> Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB IsolatesKoné Kaniga, Rumina Hasan, Ruwen Jou, et al.
The Lancet. Infectious Diseases|May 14, 2017
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling studyAditya Sharma, Andrew Hill, Ekaterina Kurbatova, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2014
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosisJ Peter Cegielski, Tracy Dalton, Martin Yagui, et al.
The Lancet. Respiratory Medicine|March 2, 2015
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studiesEkaterina V Kurbatova, J Peter Cegielski, Christian Lienhardt, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 17, 2011
European 1: a globally important clonal complex of Mycobacterium bovisNoel H Smith, Stefan Berg, James Dale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug ResistanceJ Peter Cegielski, Ekaterina Kurbatova, Martie van der Walt, et al.
Pageof 7